Torrent Pharmaceuticals
Tracked across 3 events · 23 articles · First seen Dec 30, 2025 · Last active May 26, 2026
Live sentiment trends, attention charts, and prominence tracking available on the
Ergen Dashboard
Business
Impact: Torrent Pharmaceuticals is part of a licensing partnership with Astec LifeSciences and Lupin to market generic semaglutide, aiming to enter the Indian market.
Mar 20, 2026 · 8 articles
Business
Impact: Torrent Pharmaceuticals is one of the Indian companies that launched generic semaglutide, adding to the pressure on Novo Nordisk's market share.
Mar 30, 2026 · 8 articles
Tech
Impact: Torrent Pharmaceuticals is one of the 23 leading pharmaceutical companies included in the Indian Pharmaceutical Alliance, which is a partner in the Indian AI Research Organization (IAIRO) project.
Dec 30, 2025 · 7 articles
ERGEN INTELLIGENCE
Track Torrent Pharmaceuticals live
Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.
Open Dashboard